Moneycontrol
HomeNewsBusinessExplained | How the Indian Railways is planning to attract more bidders to run trains
Trending Topics

Explained | How the Indian Railways is planning to attract more bidders to run trains

Its first round of bidding saw only two participants. Now, it is considering reduced haulage charges, and incentives for using locally made coaches and engines, among other things. Industry participants also expect the railways to ease the terms of the revenue-sharing agreement.

August 23, 2021 / 18:11 IST
Story continues below Advertisement

Representative Image

The Indian Railways is evaluating a new bidding process to make it easier and more attractive for private players to run passenger trains in India, after its first round of bidding attracted only two players.

Private entity Megha Engineering & Infrastructures Ltd and state-run Indian Railway Catering and Tourism Corp were the two. The bidding process had started in July. While the Indian Railways is yet to declare the results of the first round of bidding, reports suggest it may even be scrapped.

Story continues below Advertisement

Additionally, bids were received for only three of the 12 train clusters. Among them, one saw only a single bid – by IRCTC. Megha Engineering bid for the Delhi 1 and Delhi 2 clusters.

The Ministry of Railways had, in July, rolled out bids for private sector participation in 12 clusters. The plan involved as many as 109 origin-destination pairs and a 35-year concession period was to be provided to winning bidders on a revenue-basis model.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show